Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer

MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL) has joined with Duke University and Olink Proteomics AB to form a research collaboration to study the effects of immunotherapy on advanced gastroesophageal cancer. Specifically, the collaboration will focus on identifying composite biomarkers—those that integrate multiple biological entities into a single readout—to help guide therapeutic decision making. Gastroesophageal … [Read more…]

CDI Poised to Revolutionize Healthcare IT Solutions

Award-winning firm increases IT solutions offerings and security services for targeted industry NEW YORK–(BUSINESS WIRE)–Internationally recognized IT systems integrator, CDI (Computer Design & Integration, LLC), has announced the official establishment of CDI Healthcare, a segmented group focused on client success in the healthcare industry. CDI has tapped Robert Burgess, a 25-year Healthcare IT veteran, as … [Read more…]

Netsmart and Southeast Kansas Mental Health Center Collaborate to Deliver Integrated Care

OVERLAND PARK, Kan.–(BUSINESS WIRE)–#ArtificialIntelligence—Southeast Kansas Mental Health Center (SEKMHC) and Netsmart are advancing their 30-year partnership by upgrading SEKMHC’s adoption of the CareFabric® platform to enhance clinical, financial and operational efficiencies across the organization’s high-quality services and treatment programs. Netsmart is the leading technology partner for community mental health centers (CMHCs) in the state of … [Read more…]

Exelixis Expands Clinical Trial Collaboration and Supply Agreement with Bristol Myers Squibb to Include the Fixed-Dose Combination of Nivolumab and Relatlimab in Combination with XL092 in Phase 1b STELLAR-002 Trial

— Agreement enables evaluation of XL092 in combination with an additional immune checkpoint inhibitor — ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced the expansion of its June 2021 Clinical Trial Collaboration and Supply Agreement with Bristol-Myers Squibb Company (NYSE: BMY) to include the use of the fixed-dose combination of nivolumab and relatlimab in the … [Read more…]

Absolute Biotech Launches to Offer Antibody Reagents, Services and Expertise to Researchers Worldwide

New parent company unites multiple antibody-centric brands to deliver unique antibody solutions BOSTON–(BUSINESS WIRE)–Absolute Biotech launched today as a unified company joining together leading antibody-centric brands from around the world. Absolute Biotech specializes in antibody reagents and services, adding value to existing antibodies, reagents and kits through annotation, validation, sequencing, engineering and recombinant manufacturing. The … [Read more…]

New Survey Reveals 77% of Americans Would Rather Sleep at the Airport Than Have Root Canal Treatment

Data from Sonendo® Inc. Uncovers Strong Consumer Sentiment Toward Root Canal Therapy LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® Procedure, a less invasive alternative to traditional root canal therapy, today announced the results of its recent survey, which revealed widespread anxiety and fear surrounding traditional … [Read more…]

Veterinary Dentistry Specialists in Chadds Ford, PA Expands Clinical Team to Support Increased Demand for Services

Advanced dental care for companion animals is provided by board-certified veterinary specialists in dentistry and anesthesia CHADDS FORD, Pa.–(BUSINESS WIRE)–John Lewis, VMD, DAVDC, FF-OMFS, co-owner of Veterinary Dentistry Specialists in Chadds Ford, PA, a full-service advanced dental care practice for companion animals, is proud to announce the expansion of his clinical team to meet the … [Read more…]

Cellarity Announces Close of $121 Million Series C Financing

SOMERVILLE, Mass.–(BUSINESS WIRE)–Cellarity, a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced today the completion of a $121 million Series C financing, bringing its total funding raised to date to $274 million. In addition to participation by Flagship Pioneering and other Series B investors, four new investors participated, … [Read more…]

miRecule Enters into Strategic Collaboration with Sanofi to Accelerate Discovery and Development of a Best-in-Class Antibody-RNA Conjugate to Treat Facioscapulohumeral Muscular Dystrophy (FSHD)

Partnership combines miRecule’s unique RNA therapeutic discovery and conjugation platforms with Sanofi’s NANOBODY® technology to create a groundbreaking treatment for FSHD miRecule will receive an upfront payment with potential future milestone payments of nearly $400 million, in addition to tiered royalties Collaboration marks the first licensing transaction leveraging miRecule’s proprietary DREAmiR™ discovery platform, validating foundational … [Read more…]

Multi Radiance Medical Therapeutic Laser Receives FDA Clearance for The Treatment of Pain Associated with Fibromyalgia

SOLON, Ohio–(BUSINESS WIRE)–Multi Radiance Medical (MRM) has become the first laser therapy manufacturer to receive FDA clearance to treat pain associated with fibromyalgia. The American College of Rheumatology defines fibromyalgia as chronic widespread pain and tenderness in specific tender points characterized by muscular tenderness, pain, fatigue, and cognitive difficulties. With no known cause or cure, … [Read more…]